info@synchemia.com | sales@synchemia.com 
9766925136 
Bosutinib
Bosutinib | CAS NO: 380843-75-4 , Bosutinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells), including treatment in adults who have been recently found to have this condition and in those who can no longer benefit from other medications for CML.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Bosutinib impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Bosutinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells), including treatment in adults who have been recently found to have this condition and in those who can no longer benefit from other medications for CML. Buy Reliable and High-Purity Bosutinib Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-B30101 |
| CAS No | 380843-75-4 |
| Mol.F. | C26H29Cl2N5O3 |
| Mol.Wt. | 530.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30102 |
| CAS No | 2468737-94-0 |
| Mol.F. | C24H25Cl2N5O3 |
| Mol.Wt. | 502.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30103 |
| CAS No | 2468737-92-8 |
| Mol.F. | C25H27Cl2N5O3 |
| Mol.Wt. | 516.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30104 |
| CAS No | 380843-81-2 |
| Mol.F. | C25H27Cl2N5O3 |
| Mol.Wt. | 516.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30105 |
| CAS No | NA |
| Mol.F. | C47H46Cl4N8O6 |
| Mol.Wt. | 960.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30106 |
| CAS No | 2095306-25-3 |
| Mol.F. | C21H19Cl2N3O3 |
| Mol.Wt. | 432.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30107 |
| CAS No | 142072-71-7 |
| Mol.F. | C10H11NO4 |
| Mol.Wt. | 209.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30108 |
| CAS No | 636-93-1 |
| Mol.F. | C7H7NO4 |
| Mol.Wt. | 169.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30109 |
| CAS No | 98446-49-2 |
| Mol.F. | C7H7Cl2NO |
| Mol.Wt. | 192g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30110 |
| CAS No | NA |
| Mol.F. | C26H30ClN5O4 |
| Mol.Wt. | 512g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30111 |
| CAS No | 2095306-26-4 |
| Mol.F. | C46H44Cl4N8O6 |
| Mol.Wt. | 946.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30112 |
| CAS No | 2095306-27-5 |
| Mol.F. | C39H30Cl4N6O6 |
| Mol.Wt. | 820.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30113 |
| CAS No | 1391063-17-4 |
| Mol.F. | C26H29Cl2N5O3 |
| Mol.Wt. | 530.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30114 |
| CAS No | 380843-75-4 |
| Mol.F. | C26H29Cl2N5O3 : H2O |
| Mol.Wt. | 530.5 : 18.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30115 |
| CAS No | NA |
| Mol.F. | C27H31Cl3N5O3 |
| Mol.Wt. | 579.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30116 |
| CAS No | NA |
| Mol.F. | C26H29Cl2N5O5 |
| Mol.Wt. | 562.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
